Balanced Salt Solution Versus 0.9% Saline Infusion for Prevention of Contrast-induced Acute Kidney Injury (BASIC Trial)

PHASE3CompletedINTERVENTIONAL
Enrollment

493

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

May 31, 2019

Study Completion Date

March 31, 2020

Conditions
Acute Kidney InjuryRenal Insufficiency, ChronicContrast Media Reaction
Interventions
DRUG

CJ Plasma Solution A Injection

Intravenous plasma solution (Chloride 90 mmoL/L) at 3 mL/kg over 1 hour pre-contrast, followed by the same solution intravenously at 1.5 mL/kg/hr for 4 hours. Intra-vascular low-osmolal or iso-osmolal contrast will be used.

DRUG

CJ 0.9% Normal Saline Injection

Intravenous plasma solution (Chloride 154 mmoL/L) at 3 mL/kg over 1 hour pre-contrast, followed by the same solution intravenously at 1.5 mL/kg/hr for 4 hours. Intra-vascular low-osmolal or iso-osmolal contrast will be used.

Trial Locations (1)

110-752

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Kyungpook National University Hospital

OTHER

collaborator

National Medical Center, Seoul

OTHER

collaborator

National Health Insurance Service Ilsan Hospital

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Bundang CHA Hospital

OTHER

collaborator

Seoul St. Mary's Hospital

OTHER

collaborator

Seoul National University Boramae Hospital

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Ewha Womans University Mokdong Hospital

OTHER

collaborator

Incheon St.Mary's Hospital

OTHER

collaborator

Gachon University Gil Medical Center

OTHER

lead

Seoul National University Hospital

OTHER

NCT02799368 - Balanced Salt Solution Versus 0.9% Saline Infusion for Prevention of Contrast-induced Acute Kidney Injury (BASIC Trial) | Biotech Hunter | Biotech Hunter